338476 <common-name>2-[2-(6-bromo-2-methyl-4-oxoquinazolin-3-yl)-3-(2-methyl-1h-indol-3-yl)-4-oxo-1,2-thiazolidin-5-yl]propanoic acid</common-name> <description>2-[2-(6-bromo-2-methyl-4-oxoquinazolin-3-yl)-3-(2-methyl-1h-indol-3-yl)-4-oxo-1,2-thiazolidin-5-yl]propanoic acid is a chemical compound with the formula C24H21BrN4O4S. With an average molecular weight of 541.40 g/mol, 2-[2-(6-bromo-2-methyl-4-oxoquinazolin-3-yl)-3-(2-methyl-1h-indol-3-yl)-4-oxo-1,2-thiazolidin-5-yl]propanoic acid is a heavy molecule.</description> <cas>150391-59-6</cas> <pubchem-id>3073578</pubchem-id> <chemical-formula>C24H21BrN4O4S</chemical-formula> <weight>541.4</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T21:35:16Z</created-at> <updated-at type="dateTime">2026-08-30T21:35:16Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=C(C2=CC=CC=C2N1)C3C(=O)C(SN3N4C(=NC5=C(C4=O)C=C(C=C5)Br)C)C(C)C(=O)O</moldb-smiles> <moldb-formula>C24H21BrN4O4S</moldb-formula> <moldb-inchi>InChI=1S/C24H21BrN4O4S/c1-11(24(32)33)22-21(30)20(19-12(2)26-17-7-5-4-6-15(17)19)29(34-22)28-13(3)27-18-9-8-14(25)10-16(18)23(28)31/h4-11,20,22,26H,1-3H3,(H,32,33)</moldb-inchi> <moldb-inchikey>RVSXCFBEQFUMTC-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">540.04669</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>1.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM334369</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[2-(6-bromo-2-methyl-4-oxoquinazolin-3-yl)-3-(2-methyl-1h-indol-3-yl)-4-oxo-1,2-thiazolidin-5-yl]propanoic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Diazanaphthalenes</klass> <subklass>Benzodiazines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0288903</sync-id> <structure-inchikey>RVSXCFBEQFUMTC-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000000000000000000000000104000000000000002000000000000000000000201000800020000000000000002004000000000000000000000004000080000000000001000000000000100000000020000010000800000000800000000208000000010000000000000000900000000404000100000040040000000001100000000040000000804000200000004004000000000100000080000000000000000010000001000000840000080000400400100000000000000000000000000000001000040000000080000100008000000000000000002020004202000001000000000000000801000040200000000400000020000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJgAAAIABBgBgAAAAAQMGQCgAAAAD BAZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEG QGgAAAADAwEGQCgAAAADBAdAOAAAAAMBAwYAYAAAAAMBBgAoAAAAAwQIACgA AAADAgYAYAAAAAMBEAAgAAAAAgcAKAAAAAMDB0AoAAAAAwMGQCgAAAADBAdA KAAAAAMDBkAoAAAAAwQGQCgAAAADBAZAKAAAAAMECAAoAAAAAwIGQGgAAAAD AwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDASMAIAAAAAEGAGAAAAABAwYA YAAAAAMBBgBgAAAAAQMGACgAAAADBAgAKAAAAAMCCABoAAAAAwEBCwABAAEC aAwCA2gMAwRoDAQFaAwFBmgMBgdoDAcIaAwICWgMAgoACgsACwwIAgsNAA0O AA4PAA8QIBARaAwREmgMEhNoDBMUaAwUFWgMFRYoAhQXaAwXGGgMGBloDBka aAwYGwARHAANHQAdHgAdHwAfICgCHyEgCQFoDAgDaAwPCgAVEGgMGhNoDEIF AAAABQECAwgJBgQFBgcIAwULCg8ODQYREhMUFRAGFxgZGhMUFwQAAAAAAAAA Fg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:39:15Z</structure-indexed-at> </compound>